SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹4,082 Cr | ₹1,870 Cr | ₹2,846 Cr | ₹6,198 Cr | ₹931 Cr |
What is the latest Total Debt ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹4,082 Cr |
| Mar2025 | ₹1,870 Cr |
| Mar2024 | ₹2,846 Cr |
| Mar2023 | ₹6,198 Cr |
| Mar2022 | ₹931 Cr |
How is Total Debt of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,082 Cr | 118.31 | |
| Mar2025 | ₹1,870 Cr | -34.30 | |
| Mar2024 | ₹2,846 Cr | -54.09 | |
| Mar2023 | ₹6,198 Cr | 565.94 | |
| Mar2022 | ₹931 Cr | - | |
Compare Total Debt of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,672.6 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| MANKIND PHARMA | ₹103,468.0 Cr | 1.2% | 4.4% | 0.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -1.8% |
-7% |
14.3% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses